Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Therapeutics targeting Nogo-A hold promise for stroke restoration.

Kumar P, Moon LD.

CNS Neurol Disord Drug Targets. 2013 Mar;12(2):200-8. Review.

PMID:
23394537
[PubMed - indexed for MEDLINE]
2.

Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity.

Lee JK, Kim JE, Sivula M, Strittmatter SM.

J Neurosci. 2004 Jul 7;24(27):6209-17.

PMID:
15240813
[PubMed - indexed for MEDLINE]
Free Article
3.

Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats.

Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, Schnell L, Oertle T, Schwab ME.

J Cereb Blood Flow Metab. 2003 Feb;23(2):154-65.

PMID:
12571447
[PubMed - indexed for MEDLINE]
4.

Cognitive recovery in the aged rat after stroke and anti-Nogo-A immunotherapy.

Gillani RL, Tsai SY, Wallace DG, O'Brien TE, Arhebamen E, Tole M, Schwab ME, Kartje GL.

Behav Brain Res. 2010 Apr 2;208(2):415-24. doi: 10.1016/j.bbr.2009.12.015. Epub 2009 Dec 24.

PMID:
20035795
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Constraint-induced movement therapy overcomes the intrinsic axonal growth-inhibitory signals in stroke rats.

Zhao S, Zhao M, Xiao T, Jolkkonen J, Zhao C.

Stroke. 2013 Jun;44(6):1698-705. doi: 10.1161/STROKEAHA.111.000361. Epub 2013 Apr 30.

PMID:
23632976
[PubMed - indexed for MEDLINE]
Free Article
6.

Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.

Tsai SY, Markus TM, Andrews EM, Cheatwood JL, Emerick AJ, Mir AK, Schwab ME, Kartje GL.

Exp Brain Res. 2007 Sep;182(2):261-6. Epub 2007 Aug 24.

PMID:
17717658
[PubMed - indexed for MEDLINE]
7.

Recovery and brain reorganization after stroke in adult and aged rats.

Markus TM, Tsai SY, Bollnow MR, Farrer RG, O'Brien TE, Kindler-Baumann DR, Rausch M, Rudin M, Wiessner C, Mir AK, Schwab ME, Kartje GL.

Ann Neurol. 2005 Dec;58(6):950-3.

PMID:
16315284
[PubMed - indexed for MEDLINE]
8.

Nogo-A expression after focal ischemic stroke in the adult rat.

Cheatwood JL, Emerick AJ, Schwab ME, Kartje GL.

Stroke. 2008 Jul;39(7):2091-8. doi: 10.1161/STROKEAHA.107.507426. Epub 2008 May 8.

PMID:
18467652
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats.

Tsai SY, Papadopoulos CM, Schwab ME, Kartje GL.

Stroke. 2011 Jan;42(1):186-90. doi: 10.1161/STROKEAHA.110.590083. Epub 2010 Nov 18.

PMID:
21088244
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro.

Yan J, Zhou X, Guo JJ, Mao L, Wang YJ, Sun J, Sun LX, Zhang LY, Zhou XF, Liao H.

J Neurochem. 2012 Mar;120(5):721-31. doi: 10.1111/j.1471-4159.2011.07619.x. Epub 2012 Jan 23.

PMID:
22145612
[PubMed - indexed for MEDLINE]
11.

Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat.

Papadopoulos CM, Tsai SY, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL.

Ann Neurol. 2002 Apr;51(4):433-41.

PMID:
11921049
[PubMed - indexed for MEDLINE]
12.

Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions.

Mingorance A, Fontana X, Solé M, Burgaya F, Ureña JM, Teng FY, Tang BL, Hunt D, Anderson PN, Bethea JR, Schwab ME, Soriano E, del Río JA.

Mol Cell Neurosci. 2004 May;26(1):34-49.

PMID:
15121177
[PubMed - indexed for MEDLINE]
13.

Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A.

Weinmann O, Schnell L, Ghosh A, Montani L, Wiessner C, Wannier T, Rouiller E, Mir A, Schwab ME.

Mol Cell Neurosci. 2006 May-Jun;32(1-2):161-73. Epub 2006 May 11.

PMID:
16697217
[PubMed - indexed for MEDLINE]
14.

Nogo and Nogo receptor: relevance to schizophrenia?

Willi R, Schwab ME.

Neurobiol Dis. 2013 Jun;54:150-7. doi: 10.1016/j.nbd.2013.01.011. Epub 2013 Jan 28. Review.

PMID:
23369871
[PubMed - indexed for MEDLINE]
15.

Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.

Zhang L, Kuang X, Zhang J.

J Genet Genomics. 2011 Nov 20;38(11):515-23. doi: 10.1016/j.jgg.2011.10.001. Epub 2011 Oct 22.

PMID:
22133682
[PubMed - indexed for MEDLINE]
16.

The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.

Hunt D, Coffin RS, Anderson PN.

J Neurocytol. 2002 Feb;31(2):93-120. Review.

PMID:
12815233
[PubMed - indexed for MEDLINE]
17.

Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys.

Eslamboli A, Grundy RI, Irving EA.

Neurosci Lett. 2006 Nov 13;408(2):89-93. Epub 2006 Sep 18.

PMID:
16982144
[PubMed - indexed for MEDLINE]
18.

Role of Nogo-A in neuronal survival in the reperfused ischemic brain.

Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Schwab ME, Hermann DM.

J Cereb Blood Flow Metab. 2010 May;30(5):969-84. doi: 10.1038/jcbfm.2009.268. Epub 2010 Jan 20.

PMID:
20087369
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.

Saha N, Kolev MV, Semavina M, Himanen J, Nikolov DB.

Biochem Biophys Res Commun. 2011 Sep 16;413(1):92-7. doi: 10.1016/j.bbrc.2011.08.060. Epub 2011 Aug 22.

PMID:
21872576
[PubMed - indexed for MEDLINE]
20.

Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.

Gonzenbach RR, Zoerner B, Schnell L, Weinmann O, Mir AK, Schwab ME.

J Neurotrauma. 2012 Feb 10;29(3):567-78. doi: 10.1089/neu.2011.1752. Epub 2011 Oct 17.

PMID:
21815784
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk